Risultati di ricerca
4 giorni fa · Harrow, Inc. ha annunciato i risultati dello studio clinico di estensione in aperto ESSENCE-2 per VEVYE 0,1%, la prima e unica ciclosporina per il trattamento dei segni e dei sintomi della malattia...
2 giorni fa · Harrow’s Heroes awards. Nominations are open until Sunday, 28 July. You can submit your nomination by filling in a short form. Terms and Conditions: Nominees cannot be Councillors. Previous winners are not eligible. Nominees cannot have been nominated within the last two years. Staff members of the London Borough of Harrow cannot be nominated.
3 giorni fa · We're a multi-artform venue based in the London Borough of Harrow.
4 giorni fa · Your hub for art and culture in Harrow.
4 giorni fa · Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology-focused compounded medications.
4 giorni fa · Research Harrow's (Nasdaq:HROW) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.
6 giorni fa · High growth companies in the Pharmaceuticals-biotech industry. View Past Performance. Discover Harrow's earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers.